The size of the contraceptive devices market will reach US$ 23.72 billion

Pune, August 23, 2022 (GLOBE NEWSWIRE) — global contraceptive device market the clock is expected US$23.72 billion by 2030 due to the increasing number of government efforts helping to expand the overall market, the high rate of acceptance of contraceptive devices, and the increasing frequency of sexually transmitted diseases.

market driver

One of the main factors driving the expansion of the market is the increasing incidence of sexually transmitted diseases such as gonorrhea, chlamydia, trichomoniasis, hepatitis B and HIV/AIDS worldwide. Another factor driving market expansion is the growing awareness of the general public about the options available to prevent unintended pregnancies. In order to control population growth and stop the spread of sexually transmitted diseases. Governments in both developed and developing countries are launching programs to increase awareness and promote the use of effective contraceptives, particularly in rural regions, as a result the demand has increased significantly.

Request a sample copy of the investigation report:

Scope and segmentation of the report:

Report Coverage Details
Market size in 2021 $12.9 billion
Revenue forecast in 2030 $23.72 billion
Growth rate CAGR of 7.0% from 2022 to 2030
Base year for the estimate 2021
forecast period 2022-2030
Covered segments Product type, technology, distribution channel
regional scope North America, Europe, Asia Pacific and the rest of the world (ROW)

Excerpts from ‘Segmentation by type of product’

Based on product type, the global contraceptive devices market has been segmented into:

  • female contraceptive devices
  • Male contraceptive devices

The female contraceptive segment dominated the global contraceptive market due to the wide range of presence of female contraceptive methods, including diaphragms, intrauterine devices, subdermal implants, vaginal rings, and others, which are readily available. The market for contraceptive devices is also anticipated to grow as more women around the world take advantage of contraceptive techniques such as IUDs, sterilization, and female condoms. For example, according to the UN Department of Economic and Social Affairs, 922 million women worldwide who are of reproductive age used contraception in 2019,

See also  Minnesota Legislature Approves $1 Million Bird Flu Emergency | Health & Fitness

According to the World Health Organization, in developing regions, 214 million women of reproductive age intended to delay pregnancy as of July 2020. Furthermore, between 2015 and 2019, nearly half of all pregnancies were found to they were not wanted. Consequently, there is a significant market need for female contraceptive devices which will ultimately increase market demand.

Excerpts from ‘Segmentation by region’

Based on region, the global contraceptive devices market has been segmented into:

  • North America
  • Europe
  • Pacific Asia
  • Rest of the world

Due to the high number of unexpected pregnancies, the introduction of the Affordable Care Act in the US, and the widespread use of contraceptive devices in the region, North America dominates the global market for contraceptive devices. The expansion of the contraceptive device market in North America has been significantly attributed to favorable contraceptive reimbursement policies by large insurance companies for all federal (US) employees and their families. One of the largest consumers and providers of contraceptives in the world is the United States. For more than 50 years, the government has been involved in international family planning/reproductive health (RH/FP) initiatives and is the world’s leading donor in this area. In addition, the US recently expanded its funding for FP/RH. For example, the United States provided more than $608.0 million for FP/RH in 2020, including support to the United Nations Population Fund (UNFPA). These actions should benefit the expansion of the market, according to expectations.

During the forecast period, the Asia Pacific contraceptive devices market is anticipated to develop at the fastest rate due to factors including the region’s high population, rising disposable income, increased awareness of the benefits of contraceptives to prevent pregnancy and STDs, and the solid economy of the countries. increase. Industry leaders with larger distribution networks and more research funding have consolidated their market positions in the forecast period. Also, as a result of increased awareness, small players have been emerging in the Asia-Pacific region.

See also  Health Cloud Market Share, Growth Size, Scope and Forecast to 2028 | SAP SE (Germany), Zoho Corporation (India), Google LLC (USA), IBM Corporation (USA), Oracle Corporation ( USA)

Request customization of this research report at:

Excerpts from ‘Competitive Landscape’

Some of the key players operating in the global Contraceptive Devices market include:

  • Pfizer, Inc.
  • Merck & Co. Inc.
  • AbbVie, Inc.
  • Teva Pharmaceutical Industries Limited
  • Ansell Ltda.
  • Bayer AG
  • The Cooper Companies Inc.
  • true inc
  • Mayer Laboratories Inc.
  • Church and Dwight Co Inc.

To increase their market share and survive in a fiercely competitive market, these companies strive to develop numerous awareness campaigns and offer contraceptives at reasonable costs.

Table of Contents:

    1. market ecosystem
    2. Timeline under consideration
      1. Historical Years – 2020
      2. Base Year – 2021
      3. Projected years: 2022 to 2030
    3. Currency used in the report
    1. Research focus
    2. Data collection methodology
    3. data sources
      1. secondary sources
      2. primary sources
    4. Market estimation approach
      1. Bottom up
      2. From top to bottom
    5. Market forecast model
    6. Limitations and assumptions
    1. Current market trend (COVID-19 perspective)
    2. Key players and competitive positioning (2021)
    1. drivers
    2. restrictions
    3. Opportunities
    1. Female Contraceptive
  6. Male Contraceptive
    1. hormonal contraceptives
      1. Implant
      2. vaginal ring
      3. contraceptive patches
      4. Others
    2. barrier contraceptive
      1. condoms
      2. Diaphragms
      3. Cervical Caps
      4. sponges
      5. Intrauterine device (IUD)
      6. Others
    1. Hospital Pharmacies
    2. Retail Pharmacies
    3. online pharmacies
    4. Public channel and NGO

OCD Continue…


  • Powered by complimentary analyst hours and expert interviews with every report
  • Comprehensive quantitative and qualitative insights at the segment and sub-segment level
  • Covid 19 impact trends and outlook
  • Granular insights at the global/regional/country level
  • Deep insights into market dynamics (drivers, constraints, opportunities) and the business environment
  • General coverage of the competitive landscape
  • win imperatives
  • Comprehensive coverage on ‘Strategic Developments’ recorded by major market players
See also  It doesn't matter how you rebalance, only what you do | personal finance


  • Dealer Landscape Assessment
  • price intelligence
  • Evaluation of the customer base
  • Analysis of Investments and Initiatives
  • ‘Business profile’ of key players

Buy this Premium Report now @

About us:

Growth+Reports is part of GRG Health, a global healthcare knowledge services company. We are proud members of EPhMRA (European Pharmaceutical Marketing Research Association).

Growth+’s portfolio of services builds on our core capabilities of secondary and primary research, market modeling and forecasting, benchmarking, analysis, and strategy formulation to help clients create scalable, innovative solutions that prepare them for growth and future success.

We were awarded by the prestigious CEO Magazine as “The most innovative healthcare market research company in 2020.

The size of the contraceptive devices market will reach US$ 23.72 billion Growman Research and Consultin